Home/Filings/4/0001179110-19-006685
4//SEC Filing

Blaser Brian J 4

Accession 0001179110-19-006685

CIK 0000001800other

Filed

May 23, 8:00 PM ET

Accepted

May 24, 5:02 PM ET

Size

19.0 KB

Accession

0001179110-19-006685

Insider Transaction Report

Form 4
Period: 2019-05-23
Blaser Brian J
Senior Vice President
Transactions
  • Exercise/Conversion

    Option (right to buy)

    2019-05-2353,163120,000 total
    Exercise: $47.00From: 2018-02-20Exp: 2025-02-19Common shares (53,163 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2019-05-2356,735300,000 total
    Exercise: $38.40From: 2019-02-19Exp: 2026-02-18Common shares (56,735 underlying)
  • Exercise/Conversion

    Common shares without par value

    2019-05-23$34.94/sh+165,000$5,765,100295,745 total
  • Exercise/Conversion

    Common shares without par value

    2019-05-23$39.12/sh+175,164$6,852,416470,909 total
  • Exercise/Conversion

    Common shares without par value

    2019-05-23$47.00/sh+53,163$2,498,661524,072 total
  • Exercise/Conversion

    Common shares without par value

    2019-05-23$38.40/sh+56,735$2,178,624580,807 total
  • Sale

    Common shares without par value

    2019-05-23$75.52/sh450,062$33,988,727130,745 total
  • Exercise/Conversion

    Option (right to buy)

    2019-05-23175,1640 total
    Exercise: $39.12From: 2017-02-21Exp: 2024-02-20Common shares (175,164 underlying)
  • Exercise/Conversion

    Option (right to buy)

    2019-05-23165,0000 total
    Exercise: $34.94From: 2016-02-15Exp: 2023-02-14Common shares (165,000 underlying)
Footnotes (2)
  • [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $75.50 to $75.70, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
  • [F2]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.

Issuer

ABBOTT LABORATORIES

CIK 0000001800

Entity typeother

Related Parties

1
  • filerCIK 0001492289

Filing Metadata

Form type
4
Filed
May 23, 8:00 PM ET
Accepted
May 24, 5:02 PM ET
Size
19.0 KB